Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

GAL3ST4 Inhibitors

GAL3ST4 inhibitors are a class of chemical compounds that target and inhibit the enzyme galactose-3-O-sulfotransferase 4 (GAL3ST4). GAL3ST4 is part of the sulfotransferase family, enzymes responsible for transferring sulfate groups to various substrates, particularly carbohydrates such as galactose. This specific enzyme is involved in the sulfation of galactose-containing glycoconjugates, which are critical for various biological processes, including cell signaling and molecular recognition. By inhibiting GAL3ST4, these compounds interfere with the sulfation process, potentially altering the structure and function of glycoconjugates. GAL3ST4 inhibitors, therefore, play a role in modulating biochemical pathways where sulfated glycoconjugates are essential, such as in the biosynthesis of glycosaminoglycans (GAGs) and proteoglycans.

Inhibition of GAL3ST4 may have significant impacts on cellular interactions and extracellular matrix composition due to the alteration of sulfated glycoconjugates. Changes in the sulfation patterns of carbohydrates can influence the binding properties and interactions of these molecules with proteins and other cellular receptors, potentially affecting cell adhesion, migration, and intracellular signaling. The ability to modulate sulfation through GAL3ST4 inhibition is valuable for studying carbohydrate-protein interactions and understanding the roles of sulfated molecules in various biological contexts, including development, immune function, and extracellular matrix organization. These inhibitors serve as powerful tools in biochemical research, providing insight into the enzymatic regulation of glycosylation and sulfation pathways.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Sodium chlorate

7775-09-9sc-212938
100 g
$59.00
1
(0)

Chlorate is a competitive inhibitor of sulfotransferases and may indirectly affect GAL3ST4 expression by substrate depletion.

Pentachlorophenol

87-86-5sc-257975
1 g
$33.00
(1)

PCP is a known inhibitor of sulfotransferase activity, potentially leading to reduced GAL3ST4 function.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

A DNA methyltransferase inhibitor that can alter gene expression patterns, potentially affecting GAL3ST4.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

Another DNA methyltransferase inhibitor that might change the methylation and expression of GAL3ST4.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Inhibits eukaryotic protein synthesis, potentially reducing the production of GAL3ST4.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Binds to DNA and inhibits RNA synthesis, possibly decreasing GAL3ST4 transcription.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

An mTOR inhibitor, could affect protein synthesis regulation, potentially suppressing GAL3ST4 expression.

Puromycin dihydrochloride

58-58-2sc-108071
sc-108071B
sc-108071C
sc-108071A
25 mg
250 mg
1 g
50 mg
$42.00
$214.00
$832.00
$66.00
394
(15)

Causes premature termination of protein synthesis, possibly reducing GAL3ST4 levels.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

Inhibits RNA polymerase II, potentially reducing the transcription of GAL3ST4.

Mithramycin A

18378-89-7sc-200909
1 mg
$55.00
6
(1)

Binds to GC-rich DNA sequences and inhibits transcription, which may decrease GAL3ST4 expression.